Process for preparing novel guanidinothiazole compounds
CA 1134836 A · Owner: Yamanouchi Pharmaceutical Co. Ltd. · Inventors: Ito, Noriki; Isomura, Yasuo; Tsukamoto, Shinichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the Disclosure, Process for preparing novel guanidinothiazole compounds of the general formula:, wherein R represents a hydrogen atom or a lower alkyl group; R1 represents an amino group, a lower alkyl group a halogeno, lower alkyl group, a substituted- or unsubstituted-aryl group a mono- or di-lower alkylamino group, an arylamino group or an aralkylamino group; R2 represents a hydrogen atom a lower, alkyl group, a lower alkenyl group or a lower alkynyl group; Y represents a sulfur atom or a methylene group; m and n each represents an integer of 1 - 3; and the pharmacologically acceptable acid addition salts thereof. The guanidinothiazole compounds having gastric acid secretion …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 2, 1982. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 2, 1999.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.